• Investors
  • News
  • Careers
  • Contact
Vaxart Home Button
  • Global Need
    • Vaccines
    • History & Impact
  • Our Solution
    • Oral Vaccines
    • Technology
    • Vaccine Advantages
    • Platform Advantages
  • Pipeline
    • Research & Development
    • Norovirus
    • Influenza
    • RSV
    • HPV
  • About Us
    • Our Mission
    • Our Team
    • Careers
    • Contact
    • Compliance
  • Investors
  • News
  • Careers
  • Contact

Single

David Ingamells

Mr. Ingamells has served as our Vice President of Manufacturing since May 2015. He has 30 years of experience in the biotechnology industry, including recent roles as Vice President of Manufacturing at Optimer Pharmaceuticals (now Cubist/Merck) and Vice President of Manufacturing Operations at Molecular Medicine Bioservices (now SAFC). Previously, Mr. Ingamells held positions at BioMarin Pharmaceuticals, IDEC (now Biogen) and Genentech, with responsibilities including manufacturing, process development, engineering, facilities, validation and materials management, where he focused on the development and manufacturing of clinical and commercial enzymes, antibodies, antibiotics and viral vectors. Mr. Ingamells holds a B.S. in biochemistry from San Francisco State University.

Post navigation

Previous PostPrevious
Next PostNext
Media Contacts

Katie Hogan, WCG
415.658.9745
khogan@wcgworld.com

Samir Singh, Vaxart
908.720.622,4
ssignh@vaxart.com

Get Updates

Subscribe to receive news alerts now.

© 2022 Vaxart, Inc., All rights reserved. Terms of UsePrivacy Policy